EGFP fluorescence as an indicator of cancer cells response to methotrexate

European Journal of Pharmacology

Volumn 555, Issue 2-3, 2007, Pages 93-99

  Dabrowska, Magdalena ^a   Hendrikx, P Jan ^b   Skierski, Janusz ^c   Malinowska, Monika ^a   Bertino, Joseph R ^d   Rode, Wojciech ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c NATIONAL MEDICINES INSTITUTE   (Poland)

^d RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

Colonic carcinoma; Flow cytometry; Imaging of drug response; Methotrexate

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; METHOTREXATE;

ARTICLE; CANCER CELL; CELL CYCLE G1 PHASE; CELL GRANULE; CELL SHAPE; CELL STRUCTURE; CELL SURVIVAL; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA CONTENT; DRUG MECHANISM; DRUG SENSITIVITY; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ADENOCARCINOMA; ANTIMETABOLITES, ANTINEOPLASTIC; CELL LINE, TUMOR; CELL SURVIVAL; COLORECTAL NEOPLASMS; DNA; FLOW CYTOMETRY; FLUORESCENT DYES; FOLIC ACID ANTAGONISTS; GREEN FLUORESCENT PROTEINS; HUMANS; METHOTREXATE; MICROSCOPY, FLUORESCENCE;

EID: 33845965997     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.10.052     Document Type: Article

References (33)

1. Adams J.Y., Johnson M., Sato M., Berger F., Gambhir S.S., Carey M., Iruela-Arispe L., and Wu L. Visualization of advances human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging. Nat. Med. 8 (2002) 891-896
2. Baroja A., de la Hoz C., Alvarez A., Vielba R., Sarrat R., Arechaga J., and de Gandaris J.M. Polyploidization and exit from cell cycle as mechanisms of cultured melanoma cell resistance to methotrexate. Life Sci. 62 (1998) 2275-2282
3. Blagosklonny M.V. Carcinogenesis, cancer therapy and chemoprevention. Cell Death Differ. 12 (2005) 592-602
4. Blasberg R. PET imaging of gene expression. Eur. J. Cancer 38 (2002) 2137-2146
5. Blasberg R.G. Molecular imaging and cancer. Mol. Cancer Ther. 2 (2003) 335-343
6. Dubrovin M., Serganova I., Mayer-Kuckuk P., Ponomarev V., and Blasberg R.G. Multimodality in in vivo molecular-genetic imaging. Bioconjug. Chem. 15 (2004) 1376-1388
7. Eom Y.-W., Kim M.A., Park S.S., Goo M.J., Kwon H.J., Sohn S., Kim W.-H., Yoon G., and Choi K.S. Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype. Oncogene 24 (2005) 4765-4777
8. Georgakoudi I., Jacobson B.C., Muller M.G., Sheets E.E., Badizadegan K., Carr-Locke D.L., Crum C.P., Boone C.W., Dasari R.R., Van Dam J., and Feld M.S. NAD(P)H and collagen as in vivo quantitative fluorescent biomarkers of epithelial precancerous changes. Cancer Res. 62 (2002) 682-687
9. Gibbs D., Jackman A., and Kirkpatrick P. Pemetrexed disodium. Nat. Rev., Drug Discov. 4 (2005) S16-S17
10. Hanauske A.-R., Chen V., Paoletti P., and Niyikiza C. Pemetrexed disodium: a novel antifolate clinically active against multiple solid tumors. Oncologist 6 (2001) 363-373
11. Harrington K., Alvarez-Vallina L., Crittenden M., Gough M., Chong H., Diaz R.M., Vassaux G., Lemoine N., and Vile R. Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery. Hum. Gene Ther. 13 (2002) 1263-1280
12. Hattangadi D.K., DeMasters G.A., Walker T.D., Jones K.R., Newsham I.F., and Gewritz D.A. Influence of p53 and caspase 3 activity on cell death and senescence in response to methotrexate in the breast tumor cell. Biochem. Pharmacol. 68 (2004) 1699-1708
13. Herman S., Zurgil N., and Deutsch M. Low dose methotrexate induces apoptosis with reactive oxygen species involvement in T lymphocytic cell lines to a greater extent than in monocytic lines. Inflamm. Res. 54 (2005) 273-280
14. Hernschman H.R. Molecular imaging: looking at problems, seeing solutions. Science 302 (2003) 605-608
15. Hoffman R.M. The multiple uses of fluorescent proteins to visualize cancer in vivo. Nat. Rev., Cancer 5 (2005) 796-806
16. Li J.C., and Kaminskas E. Accumulation of DNA strand breaks and methotrexate cytotoxicity. Proc. Natl. Acad. Sci. U. S. A. 81 (1984) 5694-5698
17. Lippincott-Schwartz J., and Patterson G. Development and use of fluorescent protein markers in living cells. Science 300 (2003) 87-91
18. Longo G.S.A., Izzo J., Gorlick R., Banerjee D., Jhanwar S.C., and Bertino J.R. Characterization and drug sensitivity of four newly established colon adenocarcinoma cell lines to antifolate inhibitors of thymidylate synthase. Oncol. Res. 12 (2000) 309-314
19. Lorico A., Toffoli G., Boiocchi M., Erba E., Borggini M., Rappa G., and D'Incalci M. Accumulation of DNA strand breaks in cells exposed to methotrexate or N10-propargl-5,8-dideazafolic Acid. Cancer Res. 48 (1988) 2036-2041
20. Ntziachristos V., Ripoll J., Wang L.V., and Weissleder R. Looking and listening to light: the evolution of whole-body photonic imaging. Nat. Biotechnol. 23 (2005) 313-320
21. Rajaraman R., Rajaraman M.M., Rajaraman S.R., and Guernsey D.L. Neosis-a paradigm of self renewal in cancer. Cell Biol. Int. 29 (2005) 1084-1097
22. Serganova I., and Blasberg R. Reporter gene imaging: potential impact on therapy. Nucl. Med. Biol. 32 (2005) 763-780
23. Sinn P.L., Sauter S.L., and McCray Jr. P.B. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors-design, biosafety and production. Gene Ther. 12 (2005) 1089-1098
24. Strochova Z., and Pellman D. From polyploidy to aneuploidy, genome instability and cancer. Nat. Rev. 5 (2004) 45-54
25. Sullivan D.C., and Kelloff G. Seeing into cells. The promise of in vivo molecular imaging in Oncology. EMBO Rep. 6 (2005) 292-296
26. Sundaram M., Guernsey D.L., Rajaraman M.M., and Rajaraman R. Neosis. A novel type of cell division in cancer. Cancer Biol. Ther. 3 (2004) 207-218
27. Takimoto C.H. New antifolates: pharmacology and clinical applications. Oncologist 1 (1996) 68-81
28. Tuma R.S. A one-two punch: light-based therapy finds tumors, delivers treatment. J. Natl. Cancer Inst. 94 (2002) 1272-1274
29. Wang X., Tsao S.-W., Wong Y.-C., and Cheung A.L.M. Induction of senescent-like growth arrest as a new target in anticancer treatment. Curr. Cancer Drug Targets 3 (2003) 153-159
30. Yang M., Baranov E., Jiang P., Sun F.-X., Li X.-M., Li L., Hasegova S., Bouvet M., Al-Tuwaijri M., Chisma T., Schimada H., Moossa A.R., Penman S., and Hoffman R.M. Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 1206-1211
31. Zhang H.F., Maslov K., Stoica G., and Wang L.V. Functional photoacoustic microscopy for high-resolution and noninvasive in vivo imaging. Nat. Biotechnol. 24 (2006) 848-851
32. Zhao R., and Goldman I.D. Resistance to antifolates. Oncogene 22 (2003) 7431-7457
33. Zurgil N., Schiffer Z., Shafran Y., Kaufman M., and Deutsch M. Fluorescein fluorescence hyperpolarization of the apoptotic process. Biochem. Biophys. Res. Commun. 268 (2000) 155-163